Seasonal adherence to, and effectiveness of, subcutaneous interferon β-1a administered by RebiSmart® in patients with relapsing multiple sclerosis: results of the 1-year, observational GEPAT-SMART study

BACKGROUND: Little is known about whether tolerability and adherence to treatment can be influenced by weather and temperature conditions. The objective of this study was to assess monthly and seasonal adherence to and safety of sc IFN-β1a (Rebif®, Merck) in relapsing-remitting multiple sclerosis (R...

Descripción completa

Detalles Bibliográficos
Autores principales: Deftereos, Spyros N., Koutlas, Evangelos, Koutsouraki, Efrosini, Kyritsis, Athanassios, Papathanassopoulos, Panagiotis, Fakas, Nikolaos, Tsimourtou, Vaia, Vlaikidis, Nikolaos, Tavernarakis, Antonios, Voumvourakis, Konstantinos, Arvanitis, Michalis, Sakellariou, Dimitrios, DeLorenzo, Filippo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6218994/
https://www.ncbi.nlm.nih.gov/pubmed/30400884
http://dx.doi.org/10.1186/s12883-018-1179-0

Ejemplares similares

Ejemplares similares